• Theme Cancer Pharmacists, Clinical Trials & Research Professionals
  • Resource Type Position Statement
  • DATE 10 March 2023

Update: Safe handling of monoclonal antibodies in healthcare settings

This position statement was published in the Asia Pacific Journal of Clinical Oncology, 10 March 2023, https://doi.org/10.1111/ajco.13943

The aims were to (a) review the scientific literature on occupational risk, including exposure mechanisms and risk assessment, with regards to handling monoclonal antibodies (mABs) in healthcare settings; and (b) update the recommendations in the Clinical Oncology Society of Australia (COSA) safe handling of monoclonal antibodies in healthcare settings position statement, published in 2013.

Practitioners should follow the 14 recommendations to lower occupational risk when handling mABs. Another Position Statement update should occur in 5–10 years to ensure the currency of recommendations.

Download  download pdf